CHICAGO, Sept. 18, 2019 /PRNewswire-PRWeb/ -- Treximo is pleased to announce and welcome both Shannon Lewis-Mundt and Katherine Dale as the company's new Vice President of Clinical Operations and Vice President of Medical Writing and Transparency, respectively.
Shannon Lewis-Mundt joins Treximo as a clinical operations executive with a successful track record of building and managing global operation teams at prominent CROs, medical device, and pharmaceutical companies. With a therapeutic focus in rare disease and oncology, Shannon has 20 years of experience working across GxP environments including laboratory services, manufacturing, quality assurance, monitoring, clinical operations and project management. In addition, she is experienced in clinical development planning, strategy and risk mitigation.
Prior to joining Treximo, Shannon worked with Bellicum Pharmaceuticals where she served as the Executive Director of Clinical Operations for programs focused on cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT) and CAR T cell therapy. In her new role as Vice President of Clinical Operations, Shannon will be responsible for global leadership, strategic planning, and executive oversight of all clinical operations staff and clinical business opportunities.
Katherine Dale joins Treximo with 15+ years of experience in medical writing, medical writing management, clinical project management, and contractor/outsourced management. She is an established leader in managing the regulatory writing process and moving clinical development teams through the production of high-quality, eCTD and ICH-compliant documents.
As the Vice President of Medical Writing and Transparency at Treximo, Katherine will be developing partnerships, managing relationships, and providing forecasting, projection, and oversight of projects for Medical Writing, Disclosures (Transparency), and Quality Control for new and existing clients. She will support business development in expanding existing accounts into the Medical Writing arena, and in identifying and developing new Medical Writing opportunities. Additionally, she will oversee and monitor deliverables, timelines, and quality to ensure client satisfaction for all documents and deliverables across Medical Writing, Disclosures, and Quality Control.
About Treximo: Treximo provides best in class, results-based consulting and strategic quality project management services to the life sciences industry, with focus on Medical Device, Pharmaceutical and Biotechnology. Our methods help companies focus beyond the talent transaction and onto the strategies that will position them to win for years to come. We are experts in leading operational and quality program initiatives, providing immediate improvement to your organization with focus on speed, quality, cost, compliance, and innovation. For further information on Treximo, please visit: http://www.treximo.com
SOURCE Treximo
Advertisement
Shannon Lewis-Mundt joins Treximo as a clinical operations executive with a successful track record of building and managing global operation teams at prominent CROs, medical device, and pharmaceutical companies. With a therapeutic focus in rare disease and oncology, Shannon has 20 years of experience working across GxP environments including laboratory services, manufacturing, quality assurance, monitoring, clinical operations and project management. In addition, she is experienced in clinical development planning, strategy and risk mitigation.
Advertisement
Prior to joining Treximo, Shannon worked with Bellicum Pharmaceuticals where she served as the Executive Director of Clinical Operations for programs focused on cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT) and CAR T cell therapy. In her new role as Vice President of Clinical Operations, Shannon will be responsible for global leadership, strategic planning, and executive oversight of all clinical operations staff and clinical business opportunities.
Katherine Dale joins Treximo with 15+ years of experience in medical writing, medical writing management, clinical project management, and contractor/outsourced management. She is an established leader in managing the regulatory writing process and moving clinical development teams through the production of high-quality, eCTD and ICH-compliant documents.
As the Vice President of Medical Writing and Transparency at Treximo, Katherine will be developing partnerships, managing relationships, and providing forecasting, projection, and oversight of projects for Medical Writing, Disclosures (Transparency), and Quality Control for new and existing clients. She will support business development in expanding existing accounts into the Medical Writing arena, and in identifying and developing new Medical Writing opportunities. Additionally, she will oversee and monitor deliverables, timelines, and quality to ensure client satisfaction for all documents and deliverables across Medical Writing, Disclosures, and Quality Control.
About Treximo: Treximo provides best in class, results-based consulting and strategic quality project management services to the life sciences industry, with focus on Medical Device, Pharmaceutical and Biotechnology. Our methods help companies focus beyond the talent transaction and onto the strategies that will position them to win for years to come. We are experts in leading operational and quality program initiatives, providing immediate improvement to your organization with focus on speed, quality, cost, compliance, and innovation. For further information on Treximo, please visit: http://www.treximo.com
SOURCE Treximo
